| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/03/2005 | WO2005010142A2 Plant centromere compositions |
| 02/03/2005 | WO2005010050A1 Hetero type pentamer recombinant vaccine |
| 02/03/2005 | WO2005010047A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 02/03/2005 | WO2005010046A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | WO2005010044A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | WO2005010038A2 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 02/03/2005 | WO2005010033A1 New soluble and stabilized trimeric form of gp41 polypeptides |
| 02/03/2005 | WO2005010016A2 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 02/03/2005 | WO2005009476A1 Intravascular delivery of non-viral nucleic acid |
| 02/03/2005 | WO2005009463A2 Antigen-presenting cell vaccines and methods of use thereof |
| 02/03/2005 | WO2005009460A2 Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer |
| 02/03/2005 | WO2005009379A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009346A2 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| 02/03/2005 | WO2005009335A2 Live attenuated nidovirus vaccines |
| 02/03/2005 | WO2005009119A1 Rat model of diabetic nephropathy |
| 02/03/2005 | WO2005009115A2 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | WO2004111251A9 Modified fiber proteins for efficient receptor binding |
| 02/03/2005 | WO2004111244A3 Methods for the production of insulin in plants |
| 02/03/2005 | WO2004105477A3 Method for cloning in the rat by nuclear transfer |
| 02/03/2005 | WO2004102195A8 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/03/2005 | WO2004099441A3 Selection and evolution of chemical libraries |
| 02/03/2005 | WO2004099408A8 Novel protein and dna coding for the same |
| 02/03/2005 | WO2004083175A3 Methods for identifying enzyme inhibitors and protein kinases |
| 02/03/2005 | WO2004081175A3 Methods and compositions for purification of nucleic acid from a host cell |
| 02/03/2005 | WO2004070018A3 Vegf-b and pdgf modulation of stem cells |
| 02/03/2005 | WO2004061087A3 Methods and compositions of ecdysozoan molt inhibition |
| 02/03/2005 | WO2004047872A3 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 02/03/2005 | WO2004046321A3 Cis/trans riboregulators |
| 02/03/2005 | WO2004045527A3 Modulation of nima-related kinase 6 expression |
| 02/03/2005 | WO2004016777A8 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 02/03/2005 | WO2004012574A3 Negative selections assays, and compositions thereof |
| 02/03/2005 | WO2004006655A8 Nuclear fertility restorer genes and methods of use in plants |
| 02/03/2005 | WO2004002416A3 Methods and materials for treating human papillomavirus infections |
| 02/03/2005 | WO2004001065A3 Exhaustive selection or rna aptamers against complex targets |
| 02/03/2005 | WO2003096988A3 Tr4/tr2 response elements |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2003090515A3 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/03/2005 | WO2003087412A3 Mutation detection and identification |
| 02/03/2005 | WO2003087317A3 Methods for targeting quadruplex dna |
| 02/03/2005 | WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr |
| 02/03/2005 | WO2003079967A3 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 02/03/2005 | WO2003066894A8 Gene probes for the detection of the oenococcus species |
| 02/03/2005 | WO2003064606A3 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 02/03/2005 | WO2003062390A3 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 02/03/2005 | WO2003040317A8 Lung cancer therapeutics and diagnostics |
| 02/03/2005 | WO2003039342A3 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 |
| 02/03/2005 | WO2003025153A3 Enhanced proteins and methods for their use |
| 02/03/2005 | WO2003022222A3 Antisense modulation of protein kinase r expression |
| 02/03/2005 | WO2003010283A3 Antisense modulation of pka regulatory subunit rii beta expression |
| 02/03/2005 | WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 02/03/2005 | WO2002099119A3 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | WO2001048228A8 Methods and materials relating to gene expression |
| 02/03/2005 | WO2001025401A3 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 02/03/2005 | US20050028235 Plant fruit with elevated potassium levels |
| 02/03/2005 | US20050028234 Genetically engineered tomato comprising protein factor which enhances tolerance to chilling, oxidative stress, water-deficit and salt |
| 02/03/2005 | US20050028233 Plant fatty acid amide hydrolases |
| 02/03/2005 | US20050028232 Recombination polypeptide for use as gene transfer tool in plant genetic engineering; tissue engineering |
| 02/03/2005 | US20050028230 Expresion vector comprising nucleotide sequences coding membrane glycoprotein for use in generation of transgenic animal models for identifying modulators which reduce concentration of preferential biological agents in tissues of cells |
| 02/03/2005 | US20050028226 Vaccinia virus mva-e3L-knockout-mutants and use thereof |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026953 Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors |
| 02/03/2005 | US20050026863 Delivery of therapeutic gene products by intestinal cell expression |
| 02/03/2005 | US20050026860 Nucleolin antisense sequence for inhibition of cancer cell proliferation |
| 02/03/2005 | US20050026858 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups |
| 02/03/2005 | US20050026857 Antisense modulation of breast cancer-1 expression |
| 02/03/2005 | US20050026855 Therapeuticum and prophylacticum for malignant diseases using phenotype suppression |
| 02/03/2005 | US20050026841 Hab18g/cd147 its antagonist and application |
| 02/03/2005 | US20050026837 Novel proteins and methods for producing the proteins |
| 02/03/2005 | US20050026832 Expression vector comprising nucleotide sequences coding fibroblast growth for use in generating transgenic animal model for use in treatment and prevention of eating disorders and obesity |
| 02/03/2005 | US20050026831 inhibitors of notch signalling comprising proteins or polypeptides having notch ligand domains, multimeric proteins or polynucleotide codes for the protein or polypeptides, used in the treatment of cancer; vaccines |
| 02/03/2005 | US20050026825 Receptor |
| 02/03/2005 | US20050026824 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 02/03/2005 | US20050026815 administering to mammals genetic engineered glycoproteins for therapy of autoimmune disease selected from Addison's disease, Crohn's disease, Graves' disease, psoriasis, scleroderma, ulcerative colitis, or aquired immune deficiency syndrome |
| 02/03/2005 | US20050026804 Proteolytic enzyme for use in detergents, laundering; transformed nucleic acid |
| 02/03/2005 | US20050026293 Autonomously replicating biomolecule for use as gene transfer tool in genetic engineering |
| 02/03/2005 | US20050026292 GLYT1 conditional knock-out mice |
| 02/03/2005 | US20050026291 System for expression of genes in plants |
| 02/03/2005 | US20050026290 Using RNA interference to prevent expression of hormone signaling gene (EIN-2) in order to prolong flower longevity in plants |
| 02/03/2005 | US20050026289 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/03/2005 | US20050026288 Inducible protein expression system |
| 02/03/2005 | US20050026286 Methods and compositions for selective RNAi mediated inhibition of gene expression in mammal cells |
| 02/03/2005 | US20050026284 Nuclease inhibitor cocktail |
| 02/03/2005 | US20050026283 Using electric field modification to transfer components across cell barriers; organelle transfer; in vitro fertility |
| 02/03/2005 | US20050026280 Arabidopsis thaliana mutant for use as plant model for monitoring light absorption and photosynthesis in plants |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026269 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
| 02/03/2005 | US20050026268 Phytase from Bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/03/2005 | US20050026265 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders |
| 02/03/2005 | US20050026258 Mutant N-acetylglutamate synthase and method for L-arginine production |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026249 Preparing trangenic cells for use as bioreactors for production of glucocerebrosidase for use in treatment of gaucher's disease |
| 02/03/2005 | US20050026246 Method for generating diversity |
| 02/03/2005 | US20050026245 Use of cpg oligodeoxynucleotides to induce angiogenesis |